Skip to main content
. 2021 Apr 20;16(17):1413–1421. doi: 10.4244/EIJ-D-20-00429

Table 5. Sensitivity analyses according to different selection criteria.

Adjusted hazard ratio [95% confidence interval] p-value
Trimmed weights at 5th and 95th percentile
All-cause death 0.99 [0.72, 1.35] 0.946
Myocardial infarction 1.20 [1.00, 1.43] 0.052
Definite ST 0.89 [0.55, 1.45] 0.649
Restenosis 0.81 [0.63, 1.04] 0.096
Target lesion revascularisation 0.75 [0.60, 0.94] 0.014
Single stent implanted
All-cause death 0.98 [0.70, 1.37] 0.891
Myocardial infarction 1.16 [0.99, 1.35] 0.073
Definite ST 0.87 [0.51, 1.49] 0.607
Restenosis 0.84 [0.59, 1.21] 0.357
Target lesion revascularisation 0.80 [0.65, 0.99] 0.037
Hospitals using Orsiro
All-cause death 0.99 [0.71, 1.37] 0.942
Myocardial infarction 1.18 [0.97, 1.43] 0.101
Definite ST 0.86 [0.52, 1.42] 0.550
Restenosis 0.75 [0.58, 0.98] 0.035
Target lesion revascularisation 0.73 [0.58, 0.91] 0.006
Bioabsorbable polymer DES excluded
All-cause death 0.97 [0.71, 1.33] 0.858
Myocardial infarction 1.19 [0.99, 1.44] 0.067
Definite ST 0.88 [0.53, 1.46] 0.624
Restenosis 0.82 [0.63, 1.06] 0.122
Target lesion revascularisation 0.74 [0.59, 0.94] 0.013
Permanent polymer DES excluded
All-cause death 0.97 [0.69, 1.35] 0.839
Myocardial infarction 1.22 [0.99, 1.50] 0.056
Definite ST 0.87 [0.48, 1.58] 0.641
Restenosis 0.72 [0.55, 0.92] 0.009
Target lesion revascularisation 0.70 [0.55, 0.90] 0.005
DES: drug-eluting stent; ST: stent thrombosis